-
RRMS Patients on Long-term DMT Use Seen Less Likely to Progress to SPMS in Study
An 18-year study suggests long-term use of disease-modifying therapies (DMTs — interferon beta, glatiramer acetate) slows disease progression in RRMS.
Read more about this study and how DMTs can slow the progression of MS here.
Did you know about this? What do you think about this news?
-
1 Reply
-
Having been DXed in 1980 and on several DMTs, starting with Avonex over 20 years ago, I’m a believer that they’ve slowed my progression.
Log in to reply.